• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Environ Health Prev Med . Japanese nationwide survey to track the impact of long COVID over 3 years

tetano

Editor, Senior Moderator
Environ Health Prev Med


. 2025:30:84.
doi: 10.1265/ehpm.25-00293. Japanese nationwide survey to track the impact of long COVID over 3 years

Takuya Ozawa[SUP] 1 [/SUP], Hideki Terai[SUP] 1 2 [/SUP], Hiromu Tanaka[SUP] 1 [/SUP], Arisa Iba[SUP] 3 [/SUP], Mariko Hosozawa[SUP] 3 [/SUP], Miyuki Hori[SUP] 3 [/SUP], Yoko Muto[SUP] 3 [/SUP], Eiko Yoshida-Kohno[SUP] 3 [/SUP], Ho Namkoong[SUP] 4 [/SUP], Shotaro Chubachi[SUP] 1 [/SUP], Ryo Takemura[SUP] 5 [/SUP], Kengo Nagashima[SUP] 5 [/SUP], Yasunori Sato[SUP] 5 [/SUP], Makoto Ishii[SUP] 6 [/SUP], Hiroyasu Iso[SUP] 3 [/SUP], Koichi Fukunaga[SUP] 1 [/SUP]; Japan long COVID research group



Affiliations
Free article Abstract

Background: The long-term impact of symptom classification on quality of life (QOL) and economic outcomes among individuals with long coronavirus disease (COVID) remains poorly understood. This study aimed to clarify the situation of long COVID in Japan by analyzing patients using cluster classification.
Methods: This multicenter, retrospective cohort study enrolled 515 patients with COVID-19 and followed up for 36 months via standardized questionnaires. Patients were classified based on: 1) symptom trajectory over time and 2) symptom cluster profiles at 3 months.
Results: While the number of symptoms decreased, fatigue and dyspnea frequently persisted, whereas anosmia and dysgeusia declined. Cough and sputum decreased gradually. The proportion of patients with 5-9 symptoms increased. The mean (interquartile range) presenteeism scores were lower in the continuous (60 [50-80]) and relapse groups (65 [48-80]) than in the recovered group (70 [50-80]). The multiple symptoms cluster had the worst SF-36, presenteeism, and absenteeism scores (47.2 [44.7-49.8], 48.8 [27.5-72.5], and 10.9 [0.0-11.0], respectively).
Conclusions: Patients with continuous and multiple symptoms experienced persistently lower QOL and greater economic burden up to 36 months after COVID-19 diagnosis. The long-term effects of long COVID are not only physical but also mental and economical. Thus, further research is needed to clarify the economical and physiological impact of long COVID.

Keywords: COVID-19; Coronavirus disease 2019; Long COVID; Quality of life.

 
Back
Top Bottom